Literature DB >> 28699108

The role of epithelial-mesenchymal transition in squamous cell carcinoma of the oral cavity.

Nina Zidar1, Emanuela Boštjančič2, Marija Malgaj3, Nina Gale2, Tadej Dovšak4, Vojko Didanovič4.   

Abstract

Epithelial-mesenchymal transition (EMT) has emerged as a possible mechanism of cancer metastasizing, but strong evidence for EMT involvement in human cancer is lacking. Our aim was to compare oral spindle cell carcinoma (SpCC) as an example of EMT with oral conventional squamous cell carcinoma (SCC) with and without nodal metastases to test the hypothesis that EMT contributes to metastasizing in oral SCC. Thirty cases of oral SCC with and without nodal metastasis and 15 cases of SpCC were included. Epithelial (cytokeratin, E-cadherin), mesenchymal (vimentin, N-cadherin), and stem cell markers (ALDH-1, CD44, Nanog, Sox-2) and transcription repressors (Snail, Slug, Twist) were analyzed immunohistochemically. We also analyzed the expression of microRNAs miR-141, miR-200 family, miR-205, and miR-429. SpCC exhibited loss of epithelial markers and expression of mesenchymal markers or coexpression of both up-regulation of transcription repressors and down-regulation of the investigated microRNAs. SCC showed only occasional focal expression of mesenchymal markers at the invasive front. No other differences were observed between SCC with and without nodal metastases except for a higher expression of ALDH-1 in SCC with metastases. Our results suggest that SpCC is an example of true EMT but do not support the hypothesis that EMT is involved in metastasizing of conventional SCC. Regarding oral SCC progression and metastasizing, we have been facing a shift from the initial enthusiasm for the EMT concept towards a more critical approach with "EMT-like" and "partial EMT" concepts. The real question, though, is, is there no EMT at all?

Entities:  

Keywords:  Epithelial-mesenchymal transition; Metastasis; MicroRNA; Oral carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28699108     DOI: 10.1007/s00428-017-2192-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  39 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 2.  Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance.

Authors:  David Tarin
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.

Authors:  Sabrina Daniela da Silva; Grégoire B Morand; Faisal A Alobaid; Michael P Hier; Alex M Mlynarek; Moulay A Alaoui-Jamali; Luiz Paulo Kowalski
Journal:  Clin Exp Metastasis       Date:  2014-11-30       Impact factor: 5.150

4.  Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma.

Authors:  Lutao Du; Yongmei Yang; Xiaoyan Xiao; Chuanxin Wang; Xuhua Zhang; Lili Wang; Xin Zhang; Wei Li; Guixi Zheng; Shun Wang; Zhaogang Dong
Journal:  Oral Oncol       Date:  2011-08       Impact factor: 5.337

5.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

Authors:  Cameron P Bracken; Philip A Gregory; Natasha Kolesnikoff; Andrew G Bert; Jun Wang; M Frances Shannon; Gregory J Goodall
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck.

Authors:  Nina Zidar; Nina Gale; Nika Kojc; Metka Volavsek; Antonio Cardesa; Llucia Alos; Heinz Höfler; Kareen Blechschmidt; Karl-Friedrich Becker
Journal:  Virchows Arch       Date:  2008-08-19       Impact factor: 4.064

7.  Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition.

Authors:  Iyo Kimura; Hiroko Kitahara; Kazuhiro Ooi; Koroku Kato; Natuyo Noguchi; Kunio Yoshizawa; Hiroyuki Nakamura; Shuichi Kawashiri
Journal:  Oncol Lett       Date:  2015-10-27       Impact factor: 2.967

Review 8.  Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

Authors:  Antonio Díaz-López; Gema Moreno-Bueno; Amparo Cano
Journal:  Cancer Manag Res       Date:  2014-04-25       Impact factor: 3.989

9.  Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Authors:  Xiaofeng Zheng; Julienne L Carstens; Jiha Kim; Matthew Scheible; Judith Kaye; Hikaru Sugimoto; Chia-Chin Wu; Valerie S LeBleu; Raghu Kalluri
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

10.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more
  12 in total

Review 1.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

2.  Silenced Myeloblastosis Protein Suppresses Oral Tongue Squamous Cell Carcinoma via the microRNA-130a/Cylindromatosis Axis.

Authors:  Ran Yang; Yusen Shui; Shoushan Hu; Kun Zhang; Yuru Wang; Yiran Peng
Journal:  Cancer Manag Res       Date:  2020-08-05       Impact factor: 3.989

Review 3.  Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.

Authors:  Joanna Kałafut; Arkadiusz Czerwonka; Alinda Anameriç; Alicja Przybyszewska-Podstawka; Julia O Misiorek; Adolfo Rivero-Müller; Matthias Nees
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

4.  Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.

Authors:  Xi Chen; Yu Cao; Wafik Sedhom; Ling Lu; Yanqiu Liu; Haibo Wang; Masako Oka; Sophia Bornstein; Sherif Said; John Song; Shi-Long Lu
Journal:  Mol Oncol       Date:  2019-10-26       Impact factor: 6.603

5.  Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.

Authors:  Silas Antonio Juvencio de Freitas Filho; Cláudia Malheiros Coutinho-Camillo; Katia Klug Oliveira; Bárbara Beltrame Bettim; Clóvis Antônio Lopes Pinto; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  J Oncol       Date:  2021-02-13       Impact factor: 4.375

Review 6.  Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks.

Authors:  Sara Uhan; Nina Hauptman
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

7.  Immunohistochemical Expression of Epithelial Mesenchymal Transition Proteins in Squamous Cell Carcinoma of the Oral Cavity.

Authors:  Hamideh Kadeh; Shirin Saravani; Ebrahim Miri Moghaddam
Journal:  Iran J Pathol       Date:  2021-07-06

8.  Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Aleš Grošelj; Nina Zidar
Journal:  Biomed Res Int       Date:  2020-07-17       Impact factor: 3.411

9.  SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation.

Authors:  Wenlu Li; Dandan Zhu; Shuaihua Qin
Journal:  J Exp Clin Cancer Res       Date:  2018-07-13

10.  PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting α v integrin/FAK/Src signaling in oral squamous cell carcinoma cells.

Authors:  Gulnara Tuguzbaeva; Er Yue; Xi Chen; Lina He; Xinlei Li; Jiaming Ju; Ying Qin; Valentin Pavlov; Yanjie Lu; Wenting Jia; Yunlong Bai; Yumei Niu; Baofeng Yang
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.